NEIMETH International Pharmaceuticals PLC is a publicly traded pharmaceutical company that originated in 1997 and is headquartered in Lagos, Nigeria. Founded by a former managing director of Pfizer Products of Nigeria, the company was established to acquire certain trading assets of Pfizer International in Nigeria. Specializing in ethical and healthcare products, NEIMETH caters to the Nigerian and ECOWAS markets, offering a diverse range that includes Pyrantrin, NCP, Ciklavit, and Minicin.
The company's product categories encompass anti-infectives, anti-diabetics, anti-hypertensives, anti-malarials, and anti-fungals. As of January 24, 2024, NEIMETH's share price stands at N2.00, reflecting a market capitalization of N3.2 billion.
BOARD OF DIRECTORS
Dr. A. B. C Orjiako – Chairman
Pharm. Matthew O. Azoji - Managing Director/CEO
Mrs. Temitayo O. Nelson - Executive Director, Finance
Mazi Sam I. Ohuabunwa, - (OFR) - Non-Executive Director
Engr. Godwin E. Omene - (Non-Executive Director)
Prof. Elijah N. Sokomba - (Non-Executive Director)
Professor Maurice M. Iwu - (Non-Executive Director)
Thomas Tunbosun Osubu - (Non-Executive Director)
Phar. Sir. Ike Onyechi - (Non-Executive Director)
Mrs. Bashirat O. Odunewu (Independent Non-Executive Director).
Mrs. Roseline A. Oputa (Executive Director, Sales and Marketing)
Plot 16, Akanni Doherty Layout, Oregun Industrial Estate, Oregun, Lagos.
Phone: +2349032543202 or +2348159491935
Please login to give a review.
The NGX All-Share Index increased by 0.33% in a persistently positive trend, closing at 71,907.26 points and nearing the untested 72,000 point mark. ...
The appointment of Valentine Okelu has been announced by the board of Neimeth International Pharmaceuticals Plc as the company’s managing d...
The Nigerian equity market opened the week on a bullish note, with a significant increase in value. The market capitalization rose by 1.35 trillio...
The equity market closed flat on Tuesday as the All-Share Index (ASI) rose by 1.22 basis points or 0.002 per cent to close at 49,416.18 from 49,414.96...
Matthew Azodi, Managing Director/ Chief Executive Officer, Neimeth Pharmaceuticals Plc, has said the company is committed to its strategic expans...
Following the completion of the board meeting of Neitmeth International Pharmaceuticals Plc held in Lagos, the company has decided to float a rights i...
The equity market returned to the green zone following impressive returns from NESTLE (+2.87%), UCAP (+3.31%), and NB (+3.01%). Thus, the all-shar...
Traders were less optimistic as the market ended trading with the All-share index falling by 0.05% to close at 43,707.30 basis points on Wednesday. Th...
The Nigerian Stock Exchange (NSE) market closed with 4,016.00 deals on Thursday, March 25th, 2021, lower than the 4,018.00 deals on Wednesday, March 2...
The Nigerian Stock Exchange (NSE) market closed with 4,311.00 deals on Friday, March 19th, 2021, higher than the 4,040.00 deals on Thursday, March 18t...
The Nigerian Stock Exchange (NSE) market closed with 4,103.00 deals on Wednesday, March 17th, 2021, lower than the 4,192.00 deals on Tuesday, March 16...
The Nigerian Stock Exchange (NSE) market closed with 4,437.00 deals on Wednesday, March 10th, 2021, lower than the 4,616.00 deals on Tuesday, March 9t...
The Nigerian Stock Exchange (NSE) market closed with 4,616.00 deals on Tuesday, March 9th, 2021, lower than the 4,655.00 deals on Monday, March 8th, 2...
The Nigerian Stock Exchange (NSE) market closed with 4,673.00 deals on Monday, March 1st, 2021, higher than the 4,465.00 deals on Friday, Februa...
The Nigerian Stock Exchange (NSE) market closed with 4,393.00 deals on Friday, February 19th, 2021, lower than the 4,972.00 deals on Thursday, Februar...